instead, it may help provide context for why an individual might respond differently to GLP-1 therapy and can support more informed dosing and medication selection conversations
By activating glucagon-like peptide-1 (GLP-1) receptors, retatrutide stimulates insulin secretion and inhibits glucagon release, leading to improved blood sugar control
These findings suggest that differences in factors that regulate meal patterns as well as metabolic adaptations may contribute to the different responsiveness to these drugs
SUPPORTS OVERALL HEALTH: A well-balanced gut microbiome supports overall health
These drugs (examples include semaglutide and liraglutide) work by mimicking a natural gut hormone, making you feel full sooner and less hungry
Diagnosis may require a medical history, examination, medication review, and specialized gastric-emptying or gastrointestinal testing